SAN DIEGO, Sept. 19, 2011 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today presented a study that assessed the effects of 18 months of treatment with FORTEO ® (teriparatide [rDNA origin] ...
INDIANAPOLIS Eli Lilly has begun marketing a device for injecting its drug Forteo, the company announced Wednesday. Lilly said the Forteo Delivery Device was designed to make injection of the drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results